Bertram Pitt Selected Research

ST Elevation Myocardial Infarction

2/2020	Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials.
11/2018	Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
1/2018	Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study.
1/2018	Mineralocorticoid Receptor Antagonists in ST-Segment Elevation Myocardial Infarction.
9/2014	Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study.
3/2014	Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bertram Pitt Research Topics

Disease

273	Heart Failure 05/2024 - 01/2002
77	Myocardial Infarction 12/2023 - 04/2002
71	Chronic Renal Insufficiency 04/2024 - 03/2010
56	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2005
53	Hyperkalemia 10/2023 - 04/2003
49	Hypertension (High Blood Pressure) 01/2024 - 10/2003
42	Left Ventricular Dysfunction 04/2022 - 12/2002
20	Albuminuria 03/2024 - 10/2003
18	Renal Insufficiency (Renal Failure) 12/2023 - 01/2001
18	Systolic Heart Failure 01/2021 - 01/2006
17	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 10/2002
15	Respiratory Sounds (Crackle) 05/2024 - 01/2002
15	Fibrosis (Cirrhosis) 01/2024 - 09/2003
15	Diabetic Nephropathies (Diabetic Nephropathy) 12/2022 - 07/2015
14	Isolated Systolic Hypertension 01/2018 - 09/2004
13	Stroke (Strokes) 12/2023 - 01/2007
13	Diabetes Mellitus 01/2021 - 06/2005
13	Hypokalemia 01/2020 - 04/2003
11	Kidney Diseases (Kidney Disease) 12/2023 - 09/2004
10	Atrial Fibrillation 05/2024 - 05/2012
10	Inflammation (Inflammations) 02/2024 - 09/2003
10	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2023 - 08/2005
10	Disease Progression 12/2022 - 01/2017
10	Heart Arrest (Cardiac Arrest) 11/2021 - 04/2014
8	Cardiomyopathies (Cardiomyopathy) 04/2024 - 04/2002
8	Acute Coronary Syndrome 01/2023 - 07/2004
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 12/2003
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 06/2004
6	ST Elevation Myocardial Infarction 02/2020 - 03/2014
5	Heart Diseases (Heart Disease) 05/2024 - 02/2007
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2009
5	Hypotension (Low Blood Pressure) 01/2021 - 04/2010
4	COVID-19 10/2022 - 12/2020
4	Infarction (Infarctions) 02/2014 - 03/2004
4	Ventricular Remodeling 03/2013 - 12/2002
4	Hypertrophy 01/2013 - 12/2002
3	Proteinuria 10/2023 - 01/2008
3	Diarrhea 01/2023 - 01/2021
3	Essential Hypertension 01/2022 - 10/2003
3	Infections 05/2021 - 12/2020
3	Sudden Death 11/2018 - 06/2006
3	Coronary Disease (Coronary Heart Disease) 11/2015 - 01/2004

Drug/Important Bio-Agent (IBA)

123	Mineralocorticoid Receptor AntagonistsIBA 05/2024 - 05/2002
75	Eplerenone (Inspra)FDA LinkGeneric 05/2024 - 04/2002
57	Spironolactone (Aldactone)FDA LinkGeneric 05/2024 - 01/2002
54	PotassiumIBA 10/2023 - 03/2003
47	finerenoneIBA 05/2024 - 06/2012
44	AldosteroneIBA 01/2024 - 04/2002
35	CreatinineIBA 12/2023 - 03/2003
29	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2002
21	DiureticsIBA 05/2024 - 01/2002
20	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2006
19	AlbuminsIBA 10/2023 - 07/2011
18	patiromerIBA 02/2023 - 04/2011
17	Angiotensin Receptor AntagonistsIBA 11/2022 - 01/2002
15	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 09/2004
14	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 05/2023 - 05/2002
13	Amlodipine (Norvasc)FDA LinkGeneric 01/2018 - 10/2002
12	SodiumIBA 04/2022 - 02/2017
12	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 09/2004
11	benazepril (Briem)FDA LinkGeneric 01/2018 - 09/2004
10	Furosemide (Lasix)FDA LinkGeneric 05/2024 - 03/2015
10	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 04/2024 - 01/2021
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 05/2008
9	Torsemide (Demadex)FDA LinkGeneric 05/2024 - 06/2009
9	Natriuretic PeptidesIBA 05/2024 - 10/2015
9	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2023 - 12/2002
8	pro-brain natriuretic peptide (1-76)IBA 05/2024 - 07/2010
8	Insulin (Novolin)FDA Link 09/2023 - 04/2012
8	AngiotensinsIBA 01/2023 - 03/2003
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2012
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 01/2001
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2020 - 01/2002
7	Valsartan (Vals)FDA Link 01/2020 - 01/2007
7	Digoxin (Digitek)FDA LinkGeneric 01/2019 - 01/2002
7	CollagenIBA 12/2018 - 12/2002
6	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2021
6	ReninIBA 01/2023 - 02/2009
5	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 01/2021
5	dapagliflozinIBA 01/2023 - 10/2019
5	Irbesartan FDA LinkGeneric 01/2020 - 01/2017
5	PolymersIBA 05/2018 - 04/2011
5	LipidsIBA 02/2013 - 01/2006
4	Hemoglobins (Hemoglobin)IBA 11/2023 - 05/2018
4	candesartanIBA 01/2020 - 03/2004
4	Enalapril FDA LinkGeneric 01/2020 - 10/2003
4	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 01/2003
4	Angiotensin IIIBA 01/2018 - 10/2003
4	Valsartan Drug Combination Amlodipine FDA Link 01/2014 - 01/2011
4	aliskiren FDA Link 08/2011 - 05/2008
3	Collagen Type I (Type I Collagen)IBA 01/2023 - 05/2009
3	KBP-5074IBA 10/2021 - 01/2020
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2021 - 02/2008
3	Collagen Type III (Type III Collagen)IBA 01/2021 - 02/2020
3	flosequinanIBA 01/2017 - 11/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 01/2004

Therapy/Procedure

103	Therapeutics 05/2024 - 01/2002
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2014 - 01/2004
4	Percutaneous Coronary Intervention 06/2014 - 01/2007
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2019 - 01/2018